Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Lowered to $47.00 at JPMorgan Chase & Co.
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) had its price target decreased by investment analysts at JPMorgan Chase & Co. from $51.00 to $47.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) had its price target decreased by investment analysts at JPMorgan Chase & Co. from $51.00 to $47.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a […]
